Next Article in Journal
VLP-Based COVID-19 Vaccines: An Adaptable Technology against the Threat of New Variants
Next Article in Special Issue
Enhanced Potency and Persistence of Immunity to Varicella-Zoster Virus Glycoprotein E in Mice by Addition of a Novel BC02 Compound Adjuvant
Previous Article in Journal
12 Months Persistent Immunogenicity after Hepatitis B Vaccination in Patients with Type 2 Diabetes and Immunogenicity of Revaccination in Non-Responders: An Open-Label Randomized Controlled Trial
Previous Article in Special Issue
Vaccine Composition Formulated with a Novel Lactobacillus-Derived Exopolysaccharides Adjuvant Provided High Protection against Staphylococcus aureus
 
 
Article

Article Versions Notes

Vaccines 2021, 9(12), 1408; https://doi.org/10.3390/vaccines9121408
Action Date Notes Link
article pdf uploaded. 29 November 2021 15:20 CET Version of Record https://www.mdpi.com/2076-393X/9/12/1408/pdf-vor
article supplementary file uploaded. 29 November 2021 15:20 CET - https://www.mdpi.com/2076-393X/9/12/1408#supplementary
article xml file uploaded 6 December 2021 08:37 CET Original file -
article xml uploaded. 6 December 2021 08:37 CET Update https://www.mdpi.com/2076-393X/9/12/1408/xml
article pdf uploaded. 6 December 2021 08:37 CET Updated version of record https://www.mdpi.com/2076-393X/9/12/1408/pdf
article html file updated 6 December 2021 08:38 CET Original file -
article html file updated 30 July 2022 19:31 CEST Update https://www.mdpi.com/2076-393X/9/12/1408/html
Back to TopTop